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Abstract
Background: While higher therapeutic intensity improves motor recovery after stroke, translating ﬁndings from successful
studies is challenging without clear exercise intensity targets. We show in the DOSE trial1 more than double the steps and
aerobic minutes within a session can be achieved compared with usual care and translates to improved long-term walking
outcomes.
Objective: We modeled data from this successful higher intensity multi-site RCT to develop targets for prescribing and
progressing exercise for varying levels of walking impairment after stroke.
Methods: In twenty-ﬁve individuals in inpatient rehabilitation, twenty sessions were monitored for a total of 500 one-hour
physical therapy sessions. For the 500 sessions, step number and aerobic minute progression were modeled using linear mixed
effects regression. Using formulas from the linear mixed effects regression, targets were calculated.
Results: The model for step number included session number and baseline walking speed, and for aerobic minutes, session
number and age. For steps, there was an increase of 73 steps per session. With baseline walking speed, for every 0.1 m/s increase, a
corresponding increase of 302 steps was predicted. For aerobic minutes, there was an increase of .56 minutes of aerobic activity
(ie, 34 seconds) per session. For every year increase in age, a decrease of .39 minutes (ie, 23 seconds) was predicted.
Conclusions: Using data associated with better walking outcomes, we provide step number and aerobic minute targets that
future studies can cross-validate. As walking speed and age are collected at admission, these models allow for uptake of routine
measurement of therapeutic intensity.
Registration: www.clinicaltrials.gov; NCT01915368.
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Introduction
Frequency, intensity, time, and type, or the FITT principle, is
a way to outline the components of exercise prescription.
While interpretation of clinical trials require the components
of FITT to be depicted to allow for successful implementation, Billinger et al (2015) report that exercise intensity is only described adequately in 59% of clinical trials.2
Further, no studies outline data-driven prescription and
progression of therapeutic exercise intensity after stroke. In
the absence of speciﬁc exercise prescription guidelines, rehabilitation therapists provide low exercise doses, despite
evidence that higher intensity exercise improves neural and
functional recovery.1,3
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When general targets are given to research therapists, our
recent study shows more than double the steps and aerobic
minutes can be achieved vs usual care and translates to
improved long-term walking outcomes.1 Yet, safety concerns
keep some therapists from delivering higher exercise intensity4 since the subacute stroke period is a time of higher risk
for cardiac complications.5 A roadmap highlighting key
parameters that impact safe prescription and progression
targets based on these parameters would be a useful clinical
tool. To address this gap, we modeled data from a successful
higher intensity multi-site randomized clinical trial to develop
formulas for prescribing and progressing exercise for varying
walking impairment levels after stroke.1

Methods
These data are from the Determining Optimal Post-Stroke
Exercise (DOSE) trial (2014–20181) and involve post hoc
analysis and modeling. Brieﬂy, we undertook a protocol that
progressively increased inpatients’ step number and aerobic
minutes with weight-bearing, walking-related activities,
which resulted in clinical improvements in walking outcomes
over usual care.1 The protocol was developed with safety in
mind, speciﬁcally requiring achieving a heart rate of 40%
heart rate reserve, considered the lower bound for recommended training intensities to achieve aerobic beneﬁts.2
Additionally, it focused on completing a minimum of 30
minutes of activities that progressed in step number and
aerobic minutes over the 20 sessions and was continuously
monitored with a heart rate monitor and step counter. Assistive devices were permitted throughout the protocol.
Protocol exercises included weight-bearing (ie, not sitting on
a recumbent bike), walking-related activities which used
standard equipment in typical stroke inpatient settings like
parallel bars, overhead harness, and treadmill with and
without body weight support. Each session’s step number and
aerobic minutes were recorded by the trained physical
therapist, and weekly audits by the site research coordinator
ensured the protocol was being delivered as designed. These
data (each session’s step number and aerobic minutes) are
what was modeled in this secondary analysis. Intervention
protocol details, progression guidelines, and algorithms can
be found at https://neurorehab.med.ubc.ca/ and in the protocol paper.6 Written informed consent was provided by each
participant, and research ethics board approval was obtained
from university and hospital institution review boards. The
clinical trial consisted of 3 groups. Group 1 was usual care
which consisted of 5 1-hour sessions per week. Group 2 was
the DOSE1 intervention which replaced typical physical
therapy for 5 1-hour sessions per week for 20 sessions. Group
3 was the DOSE2 group. For this group, in addition to the
DOSE1 activity (typically morning), the DOSE2 group also
received an extra, 1-hour exercise session, 5 days/week, for 4
weeks, which occurred later in the day (ie, typically from 4 to
5 PM daily), for a total of 40 sessions. The primary outcomes
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paper showed similar walking improvement at 1-year poststroke for the DOSE1 and DOSE2 groups.1 While the trial
delivered 3 exercise intensities, the therapy time of the
DOSE1 (Group 2) is consistent with that delivered in typical
inpatient rehabilitation settings (1hr/day). Thus, this study
focused on the exercise intensity progression in this group
(n=25) over their inpatient stay.
Safety: As the protocol was generated with safety in mind,
a heart rate of 40% heart rate reserve was used as it is
considered the lower bound for recommended training intensities to achieve aerobic beneﬁts.2 During the clinical trial,
all adverse events were recorded for all participants. A data
safety monitoring board was made aware of all events, and all
serious adverse events were reported in the primary outcomes
manuscript.1 Participants received 1:1 therapy at all times
from a licensed physical therapist (±a rehabilitation assistant
who was present when necessary for low level participants
requiring 2-person assist). Additionally, the participant’s HR
was being constantly monitored by the watch, and therapists
were instructed to mitigate any safety concerns immediately.
Measures: Age, sex, and days poststroke were collected.
Baseline walking speed was the average of 2 trials of the 5 m
walk test completed at the participant’s preferred speed. The
general targets therapists were given were to achieve by the
end of 20 exercise sessions: >2000 walking steps per session
(target derived from pilot data) and complete ≥30 consecutive
aerobic minutes at an intensity ≥40% heart rate reserve, the
minimum threshold to be considered moderate aerobic intensity.2 A step counter on the non-paretic ankle (Fitbit One;
Fitbit Inc, San Francisco, California) and wrist-based heart
rate monitor (Mio Alpha; Mio Global, Vancouver, British
Columbia) were worn during each of 20 sessions. The
physical therapist used the step number and heart rate data to
provide feedback to the participant and to progress the intervention over the 20 sessions. The Fitbit One can accurately
measure steps during inpatient stroke rehabilitation physical
therapy sessions.7 The Mio Alpha has acceptable accuracy of
heart rate with r=.929 (P <.01) compared with a Polar RS400
HR chest strap as the criterion measure.8
Statistics: The intent was to develop 2 parsimonious regression models, 1 for step number and 1 for aerobic minutes,
that represented progression over 20 sessions. The following
variables were tested as predictors with rationale added in
brackets: age in years (associated with recovery and physical
activity levels), baseline walking speed (related to impairment level), session number (needed to model progression of
intensity through rehabilitation), sex (female sex associated
with greater impairment and less physical activity), and days
poststroke to study randomization (time after stroke). After
exploring the data, a linear mixed effects model was chosen
because there was nonindependence in the data due to repeated measures from participants being sampled within 6
rehabilitation units, and the aim required accounting for
within- and across-individual variability. The intracluster
correlation coefﬁcient of rehabilitation unit across 6 Canadian
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Table 1. Participant characteristics.
Mean (SD) or Count
Sex (F/M)
Age (Years)
Days (from stroke to randomization)
Baseline gait speed (m/s)
Hemisphere affected (R/L)
Stroke type (H/I)
Pre-stroke disability

9F/16M
56.04 (11.41)
26.88 (10.27)
.44 (.25)
15L/10R
3H/22I
mRS 0 = 24; mRS 1 = 1

Days = days from stroke to randomization, F = female, H = hemorrhagic, I =
ischemic, L = left, mRS = Modiﬁed Rankin Scale, M = male, R = right, SD =
standard deviation.

stroke rehabilitation centers in the primary outcomes manuscript was low (<.01); therefore, a clustering factor of rehabilitation unit was not included. For modeling, the
participant was the random effect and other factors were ﬁxed
effects. The crude relationship between the response variable
and each predictor was examined in bivariable linear mixed
effects models. Bivariable linear mixed effects can account
for correlated observations like that in a repeated measures
dataset, allows for estimation of predictor variables on outcomes, and the parameters are clear to interpret. For model
building, the independent variable with the strongest bivariable relationship with the response variable was initially
included in the model; independent ﬁxed variables were
added based on the strength of the bivariable relationship
thereafter. Iterative models were tested with the likelihood
ratio test until a new model was no longer statistically signiﬁcantly different. Together, these requirements ensured the
ﬁnal model would explain a large amount of variance in the
data and be more likely to be utilized by a front-line clinician.
The predictor variable, walking speed, was centered to make
interpretation of parameter estimates more straightforward.
Analyses were conducted using R-Project for Statistical
Computing.

Results
Participant characteristics are summarized in Table 1. As
comfortable walking speed and impairment measures are
related,9 we used walking speed as a surrogate of impairment.
Thus, using clinically meaningful functional ambulation
categories, 13 participants walked at <0.4 m/s (household
ambulation), 9 were between 0.4 m/s and 0.8 m/s (limited
community ambulation), and 3 were >0.8 m/s (full community ambulation) at baseline.10 The average baseline
walking speed was .44 (.25) m/s, average completed steps
were 2107 (1271), and average aerobic minutes 25.4 (15.6)
over 20 sessions.
Safety: Here, we report all adverse events for participants
in the DOSE1 arm of the study as these are the data that were
modeled (n=25). Three participants in the DOSE1 group
experienced adverse events.

1) For 1 participant, an open sore was observed on the
right lateral side of the ankle which was attributed to
an off-the-counter brace rubbing against the lateral
malleolus during the intervention. A dressing was
applied and the participant missed a few therapy
sessions due to ankle swelling; however, the participant was able to complete the study.
2) A participant was transferring from a wheelchair to
bed with RN supervision. The participant lost their
balance during the transfer and fell into a wall, sustaining a minor abrasion to the left elbow with no other
injuries sustained. A small dressing was applied to the
abrasion. No physical therapy sessions were missed.
3) A participant got up from bed half asleep at 2am when
they slipped off of the edge of the bed and fell onto the
ground. The participant’s head and knees hit the ﬂoor
and bruising was observed around the knees, and
headache/dizziness reported. The next day, the participant was unable to tolerate weight-bearing gaitrelated activities secondary to knee pain and
headache/dizziness. After missing 1 therapy session,
the participant was able to ﬁnish the study.
The data safety monitoring board determined that these
events were minor. All of these events are within the scope of
that observed during typical inpatient rehabilitation.

Models
The model for step number included session number and
baseline walking speed (Table 2A). The model for aerobic
minutes included session number and age (Table 2B). Sex or
days poststroke did not signiﬁcantly add to either model. For
steps, there was an increase of 73 steps per session. With
baseline walking speed, for every 0.1 m/s increase, a corresponding increase of 302 steps was predicted. For aerobic
minutes, there was an increase of .56 minutes of aerobic
activity (ie, 34 seconds) per session. For every year increase
in age, a corresponding decrease of .39 minutes (ie, 23
seconds) was predicted.

Prediction Modeling
Table 3 provides predicted step number and aerobic minutes
based on equations in Table 2 for sessions 1, 5, 10, 15, and 20.
Session 1 was chosen to give clinicians a starting target for
day 1 of therapy. Session 5, 10, 15, and 20 reﬂect the end of a
5-day workweek to give clinicians a target to reach by the end
of each week. Even a patient that walks very slowly (eg,
baseline walking speed 0.2 m/s and likely with one-person
assistance) is predicted to reach the prescribed target of 2000
steps by 20 sessions, while a mildly impaired patient at
baseline (eg, baseline walking speed at 0.8 m/s) will exceed
2000 steps on the ﬁrst session. With age, less minutes are
achieved with older age throughout rehabilitation. Yet, older
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Table 2. A: Predictors of step number.
Predictors

Estimates

CI

P

(Intercept)
Session number
Baseline walking speed

1349.56
73.19
3023.46

1030.59–1668.53
63.70–82.68
1798.36–4248.56

<.001
<.001
<.001

Random effects: σ2=367 727.57; τ00

ID=579

519.44; ICC=.61; N

ID=25;

observations=486; marginal R2=.433; conditional R2=.780

Equation
Step number = 1349.56 + 73.19 (session number) + 3023.46 (baseline walking speed-.44)
B: Predictors of aerobic minutes
Predictors
(Intercept)

Estimates
41.54

CI
20.81–62.27

Session number

.56

.39–.73

P
<.001
<.001

Age in years
Random effects: σ2=124.18; τ00
Equation

.39
ID=99.99;

ICC=.45; N

.75 to

.03

.034
observations=493; marginal R2=.117; conditional R2=.511
Minutes = 41.54 + .56 (session number) .39 (age in years)

ID=25;

Table 3. Targets for future studies to cross-validate.
Baseline walking speed (m/s)*
A: Baseline walking speed (m/s)
0.2
0.4
0.6
0.8
1.0
1.2
B. Age (years)
40
45
50
55
60
65
70

Session 1
Steps*

Session 5
Steps*

Session 10
Steps*

Session 15
Steps*

Session 20
Steps*

701
1305
1910
2515
3120
3724

994
1598
2203
2808
3412
4017

1359
1964
2569
3174
3778
4383

1725
2330
2935
3539
4144
4749

2091
2696
3301
3905
4510
5115

27
25
23
21
19
17
15

29
27
25
23
21
19
17

32
30
28
26
24
22
20

34
32
30
28
27
25
23

37
35
33
31
29
27
25

*Based on equation in Table 1A.
† Based on equation in Table 1B.

adults are predicted to progress the number of aerobic
minutes over therapy.

Discussion
The model for step number included session number and
baseline walking speed, and for aerobic minutes, session
number and age in years. As the prescription and progression
of patients poststroke with varying levels of walking impairment has never been addressed, the practical information
provided in this study will help translate this research to

front-line clinicians after future studies cross-validate the data
(Table 3). A 65-year-old person walking at 0.4 m/s is predicted to
achieve approximately 1305 steps and 17 aerobic minutes during
the ﬁrst session, with an increase to 2696 steps and 27 minutes by
session 20. The models (Table 2) and targets (Table 3) generated
with this study provide treatment prescription and progression
targets that may be easy to use if they can be cross-validated.
Clinically meaningful and lasting changes in walking endurance
were achieved based on this higher dose of stepping practice,1
suggesting these targets may be a threshold needed to obtain
lasting changes in walking outcomes after stroke. Further,
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improved walking outcomes and quality of life could be attained
using these targets and a future study could test these targets in a
new sample of individuals after stroke.
While slower comfortable walking speed is related to older
age,11 physical activity can impact this relationship12 with
even small increases of 100 steps per day improving walking
speed.11 Alternatively, faster comfortable walking speed is
linked to higher physical activity levels.13 While walking
speed is partly explained by aerobic endurance in chronic
stroke, walking outcomes can improve by focusing on increases to aerobic endurance.14 Taken together, these studies
suggest that walking speed and age may relate to changes in
physical activity measures like step number or aerobic
minutes during the subacute phase of recovery.
Because walking speed and age are routinely collected at
admission, to translate these targets to front-line clinicians,
sensors are needed to measure steps and heart rate. Given the
plethora of inexpensive commercial options on the market,
widespread uptake of routine measurement of therapeutic
exercise intensity is possible and practical. Many sensors are
already validated for use after stroke in individuals with slow
walking steps.7
There are several limitations to implementation of higher
levels of therapeutic intensity during inpatient rehabilitation,
such as a patient fatigue level, and restrictions on a clinician’s
time. Clinicians need to address multiple treatment goals
within a session beyond walking, such as upper extremity
motor impairment. Additionally, there are regulatory constraints in many healthcare systems that limit the time a
clinician has with a patient. Further, a limitation is the average
age of our sample (56), which is younger than some rehabilitation facilities, so these targets could be further tested in
older individuals. Three participants out of 25 experienced
minor adverse events, and these events did not result in deviation from the study protocol beyond delaying physical
therapy sessions; these individuals ended up participating in all
20 sessions of the protocol. However, the authors recommend
that clinicians implementing these step numbers and aerobic
minutes in their stroke patients continuously monitor HR as
well as skin integrity if a brace is being used and ensure that
any safety issues be alleviated immediately. While our sample
size (n=25) was small, a large number of sessions (n=500)
were assessed; results could be conﬁrmed with a larger sample.
Further, cross-validation was not performed with the models
because this work is intended as a brief report to guide future
research. While the results are clinically applicable, the authors
recognize that the model needs to be validated on data that it
was not trained on to be sure it is not overﬁtted and to quantify
the predictive performance of the model.

Conclusions
Baseline walking speed and age can predict therapeutic target
step number and aerobic minutes poststroke in inpatient
rehabilitation.
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